Fingerprint
Dive into the research topics of 'Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Stephen M. Ansell, Ian Flinn, Matthew H. Taylor, Branimir I. Sikic, Joshua Brody, John Nemunaitis, Andrew Feldman, Thomas R. Hawthorne, Tracey Rawls, Tibor Keler, Michael J. Yellin
Research output: Contribution to journal › Article › peer-review